Tango Therapeutics Inc.
(TNGX)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 66.39M | 59.97M | 142.75M | 28.38M | 22.89M |
| Short-Term Investments | 270.50M | 306.17M | 342.51M | 161.94M | 17.54M |
| Long-Term Investments | - | 3.42M | 1.71M | 2.28M | - |
| Other Long-Term Assets | 2.61M | 3.43M | 19.00K | 38.00K | 2.28M |
| Receivables | - | 2.00M | 2.00M | 2.00M | - |
| Inventory | - | 567.00K | 567.00K | - | - |
| Other Current Assets | 9.65M | 13.71M | 5.08M | 183.50K | 1.23M |
| Total Current Assets | 346.54M | 375.27M | 492.34M | 193.63M | 41.66M |
| Property-Plant & Equipment | 53.42M | 57.77M | 6.09M | 11.30M | 11.83M |
| Goodwill & Intangibles | - | -18.46M | - | - | - |
| Total Long-Term Assets | 56.03M | 61.20M | 7.82M | 13.62M | 14.11M |
| Total Assets | 402.57M | 436.47M | 500.15M | 207.25M | 55.76M |
| Account Payables | 2.79M | 4.45M | 3.23M | 1.84M | 670.00K |
| Deferred Revenue | 25.67M | 31.79M | 26.02M | 31.98M | - |
| Short-Term Debt | 2.08M | 3.54M | 3.01M | 959.00K | 655.00K |
| Other Current Liabilities | 15.40M | 15.72M | 8.38M | 6.14M | 24.53M |
| Total Current Liabilities | 45.94M | 55.55M | 40.69M | 40.92M | 25.85M |
| Long-Term Debt | 36.84M | 39.36M | - | 6.92M | 7.88M |
| Other Long-Term Liabilities | - | - | - | 5.00K | 14.12M |
| Total Long-Term Liabilities | 103.52M | 131.45M | 114.72M | 127.73M | 22.01M |
| Total Liabilities | 149.46M | 186.99M | 155.41M | 168.65M | 47.86M |
| Total Debt | 38.92M | 41.13M | 1.50M | 7.88M | 7.88M |
| Common Stock | 102.00K | 88.00K | 88.00K | 40.00K | 13.00K |
| Retained Earnings | -371.26M | -269.51M | -161.34M | -103.10M | -51.13M |
| Comprehensive Income | 186.00K | -3.71M | -765.00K | 17.00K | 10.00K |
| Shareholders Equity | 253.11M | 249.48M | 344.75M | 38.60M | 7.91M |
| Total Investments | 270.50M | 306.17M | 342.51M | 161.94M | 17.54M |